Hikari Power Ltd - ALDEYRA THERAPEUTICS INC ownership

ALDEYRA THERAPEUTICS INC's ticker is ALDX and the CUSIP is 01438T106. A total of 120 filers reported holding ALDEYRA THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.40 and the average weighting 0.1%.

Quarter-by-quarter ownership
Hikari Power Ltd ownership history of ALDEYRA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$134
-20.2%
20,0200.0%0.01%
-18.8%
Q2 2023$168
-15.6%
20,0200.0%0.02%
-20.0%
Q1 2023$199
+43.2%
20,0200.0%0.02%
+42.9%
Q4 2022$139
-99.9%
20,0200.0%0.01%
+16.7%
Q3 2022$107,000
+33.8%
20,0200.0%0.01%
+33.3%
Q2 2022$80,000
-10.1%
20,0200.0%0.01%
+12.5%
Q1 2022$89,000
+11.2%
20,0200.0%0.01%
+14.3%
Q4 2021$80,000
-54.5%
20,0200.0%0.01%
-61.1%
Q3 2021$176,000
-22.5%
20,0200.0%0.02%
-18.2%
Q2 2021$227,000
-4.6%
20,0200.0%0.02%
-12.0%
Q1 2021$238,000
+73.7%
20,0200.0%0.02%
+66.7%
Q4 2020$137,000
-7.4%
20,0200.0%0.02%
-21.1%
Q3 2020$148,000
-11.4%
20,020
-50.0%
0.02%
-17.4%
Q2 2020$167,000
+12.8%
40,020
-33.3%
0.02%
+9.5%
Q1 2020$148,000
-68.2%
60,020
-25.0%
0.02%
-56.2%
Q4 2019$465,000
+10.2%
80,0200.0%0.05%
+4.3%
Q3 2019$422,000
+58.1%
80,020
+79.7%
0.05%
+58.6%
Q2 2019$267,000
-33.6%
44,5200.0%0.03%
-31.0%
Q1 2019$402,000
-19.6%
44,520
-26.0%
0.04%
-25.0%
Q4 2018$500,000
-66.4%
60,190
-44.2%
0.06%
-62.9%
Q3 2018$1,488,000
+73.6%
107,8580.0%0.15%
+60.6%
Q2 2018$857,000
+5.9%
107,8580.0%0.09%
-1.1%
Q1 2018$809,000
+10.4%
107,8580.0%0.10%
+9.2%
Q4 2017$733,000
-5.7%
107,8580.0%0.09%
-13.0%
Q3 2017$777,000
+53.3%
107,8580.0%0.10%
+47.1%
Q2 2017$507,000
+169.7%
107,858
+186.4%
0.07%
+151.9%
Q1 2017$188,00037,6620.03%
Other shareholders
ALDEYRA THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Prosight Management, LP 473,446$5,625,0004.61%
Knoll Capital Management, LLC 569,405$6,765,0004.41%
SILVERARC CAPITAL MANAGEMENT, LLC 321,879$3,824,0002.09%
First Light Asset Management, LLC 2,624,001$31,173,0002.07%
Mesirow Financial Investment Management, Inc. 63,634$756,0002.06%
Ghost Tree Capital, LLC 650,000$7,722,0001.82%
Altium Capital Management LP 548,225$6,513,0001.81%
Perceptive Advisors 8,703,879$103,402,0001.31%
Affinity Asset Advisors, LLC 300,000$3,564,0001.21%
Avidity Partners Management LP 2,552,000$30,318,0000.84%
View complete list of ALDEYRA THERAPEUTICS INC shareholders